Zhong Guo Jing Ji Wang·2025-07-17 07:27Core Viewpoint - The company Kaisheng New Materials (301069.SZ) is planning a shareholder inquiry transfer of 20 million shares, representing 4.75% of its total share capital, primarily due to the financial needs of its major shareholder, Huabang Health (002004) [1][2]. Group 1: Shareholder Transfer Details - The total number of shares to be transferred by Huabang Health is 20,000,000, which constitutes 4.75% of Kaisheng New Materials' total share capital and 10.68% of Huabang Health's holdings [2]. - The transfer will not occur through centralized bidding or block trading, and the acquiring party must be an institutional investor with appropriate pricing and risk-bearing capabilities [2]. Group 2: Company Financials and Fundraising - Kaisheng New Materials raised a total of 310.20 million yuan from its initial public offering (IPO) in 2021, with a net amount of 281.89 million yuan, which was 26.81 million yuan less than originally planned [3]. - The company intended to raise 550 million yuan for various projects, including the expansion of a 20,000-ton aromatic polymer monomer facility and a 2,000-ton/year polyether ketone resin project [3]. - The total fundraising amount from two rounds of financing is 960.20 million yuan [5]. Group 3: Convertible Bond Issuance - Kaisheng New Materials has been approved to publicly issue convertible bonds totaling 650 million yuan, with each bond having a face value of 100 yuan [4]. - As of December 5, 2023, the company had issued 6.5 million convertible bonds, and the actual funds received amounted to approximately 639.73 million yuan after deducting underwriting fees [4].